Storia in 2 fonti

Medicare’s Drug-Pricing Proposal Carries A Hidden Cost

The Trump administration says it wants to accelerate medical innovation. Yet one new proposal from the Centers for Medicare and Medicaid Services could do just the opposite.

Raccontata da

washingtonexaminer.com

forbes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

forbes.comStai leggendo4 g fa

Medicare’s Drug-Pricing Proposal Carries A Hidden Cost

The Trump administration says it wants to accelerate medical innovation. Yet one new proposal from the Centers for Medicare and Medicaid Services could do just the opposite.

originale

washingtonexaminer.com6 g fa

Medicare is about to penalize the science that saves cancer patients hours of pain

CMS's drug pricing rule penalizes subcutaneous cancer innovations, threatening medical progress that saves patients hours of pain.

Leggi questa versione → originale

Timeline cronologica

venerdì 7 agosto 2026·washingtonexaminer.com
Medicare is about to penalize the science that saves cancer patients hours of pain
CMS's drug pricing rule penalizes subcutaneous cancer innovations, threatening medical progress that saves patients hours of pain.
lunedì 10 agosto 2026·forbes.com
Medicare’s Drug-Pricing Proposal Carries A Hidden Cost
The Trump administration says it wants to accelerate medical innovation. Yet one new proposal from the Centers for Medicare and Medicaid Services could do just the opposite.